Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses
Jonathan T. Lei(Baylor College of Medicine), Michael T. Lewis(Baylor College of Medicine), Senthil Damodaran(The University of Texas MD Anderson Cancer Center), Bo Wen(University of Washington), Suhas Vasaikar(Baylor College of Medicine), Gerburg M. Wulf(Beth Israel Deaconess Medical Center), Antrix Jain(Baylor College of Medicine), Christina Sallas(Baylor College of Medicine), Meenakshi Anurag(Baylor College of Medicine), Shunqiang Li(Washington University in St. Louis), Alaina Lewis(Baylor College of Medicine), Chen Huang(Baylor College of Medicine), Lacey E. Dobrolecki(Baylor College of Medicine), Xi Chen(University of Miami), Alexander B. Saltzman, Matthew J. Ellis(Guardant (United States)), Elisabetta Marangoni(Institut Curie), Daniel C. Kraushaar(University of Georgia), Gloria V. Echeverria(Baylor College of Medicine), Yuxing Liao(Baylor College of Medicine), Na Zhao(Baylor College of Medicine), Mothaffar F. Rimawi(Baylor College of Medicine), Susan G. Hilsenbeck(Baylor College of Medicine), Chang In Moon(Baylor College of Medicine), Funda Meric‐Bernstam(The University of Texas MD Anderson Cancer Center), Bryan E. Welm(University of Minnesota), John D. Landua(Baylor College of Medicine), Ramakrishnan Rajaram Srinivasan(Baylor College of Medicine), Anna Malovannaya(Baylor College of Medicine), Bing Zhang(Baylor Genetics), Kai Li(Chinese Academy of Agricultural Sciences), Tao Wang(First Affiliated Hospital of Jiangxi Medical College), Xiaofeng Zheng(Peking University), Jin Cao(Union Hospital), Varduhi Petrosyan(American University of Armenia), C. Kent Osborne(Baylor College of Medicine), Alana L. Welm(Huntsman Cancer Institute)
Cited by 3
Related Papers
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k